Back to top

Can Novavax, Inc. (NVAX) Continue to Rise?

Read MoreHide Full Article
Investors have definitely seen some solid trading in Novavax, Inc. (NVAX) lately, leading to gains for some. However, NVAX is now in overbought territory thanks to its latest move, as the firm has an RSI value of 71.1. Additionally, Novavax, Inc. currently has a Zacks Rank #4 (Sell), so if the earnings estimate trend is any guide, a fall might be coming for this overbought stock.

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Novavax, Inc. (NVAX) - free report >>

More from Zacks Tale of the Tape

You May Like

Published in